<DOC>
	<DOCNO>NCT00897455</DOCNO>
	<brief_summary>RATIONALE : Studying sample DNA laboratory woman BRCA1/BRCA2 mutation carrier may help doctor learn cancer identify biomarkers related cancer . PURPOSE : This research study look breast cancer risk woman BRCA1/BRCA2 mutation carrier .</brief_summary>
	<brief_title>Studying Breast Cancer Risk Women Who Are BRCA1/BRCA2 Mutation Carriers</brief_title>
	<detailed_description>OBJECTIVES : - To identify potential genetic modifier breast cancer risk contribute data genetic information obtain woman BRCA1/BRCA2 mutation carrier enrol clinical trial GOG-0199 international consortium clinical cancer genetics investigator ( CIMBA ) . OUTLINE : This multicenter study . Patients stratify study , country residence , ethnicity , birth cohort . Joint analysis BRCA1 BRCA2 mutation carrier stratify mutation . Previously collect DNA sample analyze genetic variant select candidate gene ( rs16942 BRCA1 , rs2237060 RAD50 , `` SNP3 '' , rs2241193 IGFBP5 ) . The single nucleotide polymorphism ( SNP ) data study select demographic , clinical , epidemiological data obtain baseline questionnaire administer GOG-0199 study submit Consortium Investigators Modifiers BRCA-Associated Cancer ( CIMBA ) Central Database . The epidemiological SNP data contribute Central Database distribute investigator responsible analysis particular SNP set SNPs candidate gene genetic pathway .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Known positive BRCA1/BRCA2 mutation carrier With without personal history breast cancer prior enrollment clinical trial GOG0199 Currently enrol clinical trial GOG0199 AND meet follow criterion : Completed baseline questionnaire ( BQ199 ) Provided information prior breast cancer history , include date diagnosis Provided complete data DNA analysis genetic variant interest Signed approve informed consent authorization permit release personal health information Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>BRCA1 mutation carrier</keyword>
	<keyword>BRCA2 mutation carrier</keyword>
</DOC>